Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

69.05 -0.77 (-1.10%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,726,201
Open 69.65
Bid (Size) 69.00 (1)
Ask (Size) 69.05 (3)
Prev. Close 69.82
Today's Range 67.52 - 69.80
52wk Range 62.34 - 142.00
Shares Outstanding 400,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ROSEN, NATIONAL TRIAL LAWYERS, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Performance

YTD
-43.90%
-43.90%
1 Month
-4.67%
-4.67%
3 Month
-41.52%
-41.52%
6 Month
-48.36%
-48.36%
1 Year
-31.18%
-31.18%

More News

Read More
Abbott's 'Transformative' Move And Answer To Dexcom's Newest Device
Via Investor's Business Daily
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Is DexCom a Millionaire-Maker Stock?
Via The Motley Fool
Dexcom to Showcase Transformational Impact of Dexcom CGM Technology at the EASD 2024 Conference Symposium
From DexCom, Inc.
Via Business Wire
DEXCOM, INC. (NASDAQ: DXCM) DEADLINE ALERT: Bernstein Liebhard LLP Reminds DexCom, Inc. Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
Shareholder Rights Law Firm Robbins LLP Urges DXCM Stockholders with Large Losses to Contact the Firm for Information About the DexCom Inc. Lawsuit
From Robbins LLP
Via Business Wire
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $38,000 Today
Via Benzinga
Why NASDAQ:DXCM Is a Promising High-Growth Stock in the Midst of Consolidation.
Via Chartmill
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Methode Electronics, DexCom, Endava, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Dexcom Inc. (DXCM) Investors
From Kirby McInerney LLP
Via Business Wire
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of DexCom
From Faruqi & Faruqi LLP
Via GlobeNewswire
ROSEN, A TOP RANKED LAW FIRM, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
DXCM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that DexCom, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Dexcom Announces Upcoming Conference Presentation
From DexCom, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Spire Global, DexCom, and Orthofix and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
DXCM Class Action Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the DexCom Inc. Class Action
From Robbins LLP
Via GlobeNewswire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against DexCom, Inc. (DXCM)
From Glancy Prongay & Murray LLP
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of DexCom, Inc. (DXCM) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Dexcom's Stelo Device Brings Affordable Continuous Glucose Monitoring To Type 2 Diabetes Patients
Via Benzinga
Will New 'Milestone' Glucose Monitor Help Dexcom Stock Bounce Back?
Via Investor's Business Daily
DXCM INVESTOR ALERT: DexCom, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
Stelo by Dexcom, the First Over-the-Counter Glucose Biosensor in the U.S., Is Now Available
From DexCom, Inc.
Via Business Wire
ROSEN, LEADING INVESTOR COUNSEL, Encourages DexCom, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DXCM
From The Rosen Law Firm PA
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.